| Primary |
| Lung Neoplasm Malignant |
17.5% |
| Product Used For Unknown Indication |
17.5% |
| Pruritus |
17.5% |
| Medical Diet |
15.0% |
| Hodgkin's Disease |
12.5% |
| Hypopharyngeal Cancer |
7.5% |
| Rhinitis Allergic |
7.5% |
| Breast Cancer |
2.5% |
| Rash |
2.5% |
|
| Postpartum Haemorrhage |
22.2% |
| Caesarean Section |
11.1% |
| Dyspnoea |
11.1% |
| Hyponatraemia |
11.1% |
| Palmar-plantar Erythrodysaesthesia Syndrome |
11.1% |
| Pyrexia |
11.1% |
| Respiratory Disorder |
11.1% |
| Thrombocytopenia |
11.1% |
|
| Secondary |
| Premedication |
31.9% |
| Product Used For Unknown Indication |
15.7% |
| Breast Cancer |
4.6% |
| Drug Use For Unknown Indication |
4.6% |
| Chronic Lymphocytic Leukaemia |
4.5% |
| Insomnia |
3.7% |
| Prophylaxis |
3.7% |
| Pruritus |
3.2% |
| Lymphoma |
2.8% |
| Hypertension |
2.8% |
| Chemotherapy |
2.6% |
| Pain |
2.6% |
| Constipation |
2.5% |
| Depression |
2.5% |
| Asthma |
2.3% |
| B-cell Lymphoma |
2.2% |
| Infection |
2.1% |
| Wound Complication |
2.1% |
| Convulsion Prophylaxis |
1.9% |
| Ill-defined Disorder |
1.9% |
|
| Malaise |
12.7% |
| Thrombocytopenia |
7.8% |
| Vomiting |
7.2% |
| Oxygen Saturation Decreased |
6.6% |
| Sepsis |
5.4% |
| Hypothyroidism |
4.8% |
| Neuropathy Peripheral |
4.8% |
| Pruritus |
4.8% |
| Dyspnoea |
4.2% |
| Hepatic Function Abnormal |
4.2% |
| Loss Of Consciousness |
4.2% |
| Pyrexia |
4.2% |
| Somnolence |
4.2% |
| Stevens-johnson Syndrome |
4.2% |
| Syncope |
4.2% |
| Tremor |
3.6% |
| Urticaria |
3.6% |
| Erythema |
3.0% |
| Hot Flush |
3.0% |
| Rash |
3.0% |
|
| Concomitant |
| Premedication |
18.9% |
| Prophylaxis |
17.4% |
| Product Used For Unknown Indication |
13.8% |
| Drug Use For Unknown Indication |
9.8% |
| Renal Cell Carcinoma |
4.5% |
| Hypertension |
4.3% |
| Colon Cancer |
4.2% |
| Rheumatoid Arthritis |
3.5% |
| Rectal Cancer |
3.1% |
| Non-hodgkin's Lymphoma |
2.6% |
| Lymphoma |
2.2% |
| Constipation |
2.1% |
| Insomnia |
1.9% |
| Colorectal Cancer |
1.9% |
| Antiemetic Supportive Care |
1.9% |
| Hiv Infection |
1.8% |
| Breast Cancer |
1.7% |
| Pain |
1.7% |
| Hepatitis C |
1.4% |
| Cancer Pain |
1.3% |
|
| Vomiting |
12.7% |
| White Blood Cell Count Decreased |
11.9% |
| Pyrexia |
9.2% |
| Sepsis |
5.9% |
| Pneumonia |
5.3% |
| Infusion Related Reaction |
5.2% |
| Rash |
5.0% |
| Urticaria |
4.5% |
| Death |
3.9% |
| Nausea |
3.9% |
| Platelet Count Decreased |
3.9% |
| Interstitial Lung Disease |
3.8% |
| Thrombocytopenia |
3.8% |
| Bone Marrow Failure |
3.3% |
| Diarrhoea |
3.1% |
| Pruritus |
3.1% |
| Malaise |
3.0% |
| Pleural Effusion |
3.0% |
| Stomatitis |
2.8% |
| Toxic Skin Eruption |
2.8% |
|
| Interacting |
| Acute Promyelocytic Leukaemia |
85.7% |
| Infection |
14.3% |
|
| Drug Interaction |
66.7% |
| Myositis |
33.3% |
|
